As of 2024-12-14, the Intrinsic Value of Johnson & Johnson (JNJ) is
175.73 USD. This JNJ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 146.62 USD, the upside of Johnson & Johnson is
19.90%.
The range of the Intrinsic Value is 110.11 - 428.83 USD
175.73 USD
Intrinsic Value
JNJ Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
110.11 - 428.83 |
175.73 |
19.9% |
| DCF (Growth 10y) |
117.48 - 416.46 |
179.47 |
22.4% |
| DCF (EBITDA 5y) |
70.76 - 95.18 |
81.28 |
-44.6% |
| DCF (EBITDA 10y) |
84.75 - 114.76 |
97.69 |
-33.4% |
| Fair Value |
146.28 - 146.28 |
146.28 |
-0.23% |
| P/E |
168.03 - 228.94 |
193.51 |
32.0% |
| EV/EBITDA |
89.44 - 162.33 |
127.66 |
-12.9% |
| EPV |
112.03 - 158.49 |
135.26 |
-7.7% |
| DDM - Stable |
75.08 - 366.06 |
220.57 |
50.4% |
| DDM - Multi |
102.90 - 361.09 |
156.89 |
7.0% |
JNJ Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
353,005.25 |
| Beta |
-0.03 |
| Outstanding shares (mil) |
2,407.62 |
| Enterprise Value (mil) |
380,580.25 |
| Market risk premium |
4.60% |
| Cost of Equity |
6.59% |
| Cost of Debt |
5.07% |
| WACC |
6.43% |